Mary Sherlock

3.6k total citations · 1 hit paper
35 papers, 1.8k citations indexed

About

Mary Sherlock is a scholar working on Genetics, Surgery and Epidemiology. According to data from OpenAlex, Mary Sherlock has authored 35 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Genetics, 13 papers in Surgery and 10 papers in Epidemiology. Recurrent topics in Mary Sherlock's work include Inflammatory Bowel Disease (19 papers), Microscopic Colitis (10 papers) and Eosinophilic Esophagitis (9 papers). Mary Sherlock is often cited by papers focused on Inflammatory Bowel Disease (19 papers), Microscopic Colitis (10 papers) and Eosinophilic Esophagitis (9 papers). Mary Sherlock collaborates with scholars based in Canada, United States and Netherlands. Mary Sherlock's co-authors include Anne M. Griffiths, Thomas D. Walters, Jeffrey S. Hyams, Richard K. Russell, James Markowitz, David C. Wilson, Arie Levine, Marla Dubinsky, Dan Turner and Frank M. Ruemmele and has published in prestigious journals such as Gastroenterology, Cochrane Database of Systematic Reviews and British Journal Of Nutrition.

In The Last Decade

Mary Sherlock

33 papers receiving 1.8k citations

Hit Papers

Pediatric modification of the Montreal classification for... 2010 2026 2015 2020 2010 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Sherlock Canada 11 1.4k 955 761 345 190 35 1.8k
Stephan Buderus Germany 19 1.2k 0.8× 838 0.9× 735 1.0× 321 0.9× 114 0.6× 56 2.0k
Małgorzata Sładek Poland 17 1.2k 0.9× 843 0.9× 653 0.9× 301 0.9× 108 0.6× 44 1.7k
John Fell United Kingdom 18 1.5k 1.1× 1.1k 1.1× 818 1.1× 374 1.1× 181 1.0× 29 2.0k
Javier Martín de Carpi Spain 14 1.1k 0.8× 729 0.8× 650 0.9× 266 0.8× 86 0.5× 57 1.6k
Leonard Baidoo United States 21 1.7k 1.2× 1.4k 1.5× 629 0.8× 277 0.8× 152 0.8× 77 2.0k
Guillaume Bouguen France 30 1.8k 1.3× 1.3k 1.3× 1.3k 1.8× 288 0.8× 237 1.2× 144 2.8k
M Veyrac France 17 1.2k 0.9× 1.1k 1.2× 685 0.9× 290 0.8× 236 1.2× 47 2.1k
Marla Dubinsky United States 9 1.5k 1.1× 1.1k 1.1× 585 0.8× 496 1.4× 149 0.8× 19 1.8k
Marian Pfefferkorn United States 15 1.3k 0.9× 940 1.0× 467 0.6× 261 0.8× 181 1.0× 21 1.6k
Gwénola Vernier-Massouille France 14 1.5k 1.1× 1.2k 1.2× 624 0.8× 285 0.8× 174 0.9× 22 1.7k

Countries citing papers authored by Mary Sherlock

Since Specialization
Citations

This map shows the geographic impact of Mary Sherlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Sherlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Sherlock more than expected).

Fields of papers citing papers by Mary Sherlock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Sherlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Sherlock. The network helps show where Mary Sherlock may publish in the future.

Co-authorship network of co-authors of Mary Sherlock

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Sherlock. A scholar is included among the top collaborators of Mary Sherlock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Sherlock. Mary Sherlock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huynh, Hien Q., Kevan Jacobson, David Mack, et al.. (2025). Neutrophil-to-Lymphocyte Ratio at Diagnosis Predicts Colonoscopic Activity in Pediatric Inflammatory Bowel Diseases. Clinical and Translational Gastroenterology. 16(4). e00824–e00824. 1 indexed citations
2.
Cellucci, Tania, Robert M. Issenman, Nikhil Pai, et al.. (2025). Silent Struggles: Uncovering Mental Health Burdens in Adolescents with Inflammatory Bowel Disease and Juvenile Idiopathic Arthritis—A Retrospective Chart Review. Children. 12(8). 995–995. 1 indexed citations
3.
Kuenzig, M Ellen, Thomas D. Walters, David Mack, et al.. (2024). High Healthcare Costs in Childhood Inflammatory Bowel Disease: Development of a Prediction Model Using Linked Clinical and Health Administrative Data. Inflammatory Bowel Diseases. 31(4). 1018–1031. 2 indexed citations
5.
Hill, Lee, Jelena Popov, Emily Hartung, et al.. (2023). Physical Activity in Pediatric Inflammatory Bowel Disease: A Scoping Review. Pediatric Exercise Science. 36(1). 44–56. 1 indexed citations
7.
Sherlock, Mary, Mary Zachos, Robert M. Issenman, & Daniel J. Mulder. (2020). Clinical and Laboratory Characteristics Are Associated With Biologic Therapy Use in Pediatric Inflammatory Bowel Disease: A Retrospective Cohort Study. Journal of the Canadian Association of Gastroenterology. 4(5). e92–e100. 2 indexed citations
8.
Mack, David, Eric I. Benchimol, Jeff Critch, et al.. (2019). Canadian Association of Gastroenterology Clinical Practice Guideline for the Medical Management of Pediatric Luminal Crohn's Disease. Gastroenterology. 157(2). 320–348. 47 indexed citations
9.
Narula, Neeraj, Amit Dhillon, Dongni Zhang, et al.. (2018). Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews. 2018(4). 214 indexed citations
10.
Mulder, Daniel J., et al.. (2018). NMDA‐receptor Antagonism in Pediatric Pancreatitis. Journal of Pediatric Gastroenterology and Nutrition. 66(5). e134–e136. 1 indexed citations
11.
Carman, Nicholas, Peter Church, David Mack, et al.. (2018). Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn’s disease. Gastrointestinal Endoscopy. 89(2). 364–372. 28 indexed citations
12.
Crowley, Eileen, Nicholas Carman, Karen Frost, et al.. (2017). P460 Early use of therapeutic drug monitoring to individualize infliximab therapy in paediatric IBD: a multicentre prospective COHORT study. Journal of Crohn s and Colitis. 11(suppl_1). S312–S312. 1 indexed citations
13.
Zolkipli, Zarazuela, Mary Sherlock, W. Douglas Biggar, et al.. (2012). Abnormal fatty acid metabolism in spinal muscular atrophy may predispose to perioperative risks. European Journal of Paediatric Neurology. 16(5). 549–553. 35 indexed citations
14.
Sherlock, Mary & Anne M. Griffiths. (2012). Medical Therapy for Pediatric Inflammatory Bowel Disease. Current Gastroenterology Reports. 14(2). 166–173. 11 indexed citations
15.
Sherlock, Mary, Thomas D. Walters, Merit M. Tabbers, et al.. (2012). Infliximab‐Induced Psoriasis and Psoriasiform Skin Lesions in Pediatric Crohn Disease and a Potential Association With IL‐23 Receptor Polymorphisms. Journal of Pediatric Gastroenterology and Nutrition. 56(5). 512–518. 59 indexed citations
16.
Walsh, Catharine M., Mary Sherlock, Simon C. Ling, & Heather Carnahan. (2012). Virtual reality simulation training for health professions trainees in gastrointestinal endoscopy. Cochrane Database of Systematic Reviews. 8(6). CD008237–CD008237. 156 indexed citations
17.
Levine, Arie, Anne M. Griffiths, James Markowitz, et al.. (2010). Pediatric modification of the Montreal classification for inflammatory bowel disease. Inflammatory Bowel Diseases. 17(6). 1314–1321. 1054 indexed citations breakdown →
18.
Sherlock, Mary, Thomas D. Walters, Mary Zachos, Aleixo M. Muise, & Anne M. Griffiths. (2009). W1177 Infliximab-Induced Psoriasis in Pediatric Crohn Disease; Experience of This Paradoxical Skin Manifestation At a Tertiary Centre and a Potential Association with a Variation in the IL-23r Gene. Gastroenterology. 136(5). A–671. 3 indexed citations
19.
Sherlock, Mary. (1964). VON WILLEBRAND'S DISEASE. The Medical Journal of Australia. 2(11). 565–565. 5 indexed citations
20.
Sherlock, Mary, et al.. (1963). ON THE BLEEDER: A CASE OF VON WILLEBRAND'S DISEASE AND ITS TREATMENT WITH HUMAN ANTI‐HÆMOPHILIC FACTOR. The Medical Journal of Australia. 2(11). 453–455. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026